Riociguat for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension-Reference-Cited by-同舟云学术

Riociguat for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

Published:2014-11-01 Issue:21 Volume:71 Page:1839-1844
ISSN:1079-2082
Container-title:American Journal of Health-System Pharmacy
language:en
Short-container-title:

Author:

Bishop Bryan M.¹

Affiliation:

1. Department of Pharmacy, St. Rita’s Medical Center, Lima, OH, and Assistant Professor, Rudolph H. Raabe College of Pharmacy, Ohio Northern University, Ada, OH

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Link

http://academic.oup.com/ajhp/article-pdf/71/21/1839/28373539/ajhp1839.pdf

Reference27 articles.

1. Primary pulmonary hypertension;Rubin;N Engl J Med,1997

2. ACCF/AHA 2009 expert consensus document on pulmonary hypertension;McLaughlin;Circulation,2009

3. Deleterious effects of beta-blockers on exercise capacity and hemodynamics in patients with portopulmonary hypertension;Provencher;Gastroenterology,2006

4. Perspectives on novel therapeutic strategies for right heart failure in pulmonary arterial hypertension: lessons from the left heart;Handoko;Eur Respir Rev,2010

5. Food and Drug Administration. FDA approves Adempas to treat pulmonary hypertension. www.fda.gov/newsevents/newsroom/pressannouncements/ucm370866.htm (accessed 2014 Mar 5).

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FOCUS on sequelae of acute pulmonary embolism: does it pay off?;European Heart Journal;2022-05-03

2. Ventilation-Perfusion Scan;A Medication Guide to Internal Medicine Tests and Procedures;2022

3. Efficacy and safety of riociguat in the treatment of chronic thromboembolic pulmonary arterial hypertension;Medicine;2021-06-04

4. Druggability of Coronary Artery Disease Risk Loci;Circulation: Genomic and Precision Medicine;2018-08

5. Tetrandrine prevents monocrotaline-induced pulmonary arterial hypertension in rats through regulation of the protein expression of inducible nitric oxide synthase and cyclic guanosine monophosphate-dependent protein kinase type 1;Journal of Vascular Surgery;2016-11